Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ solutions as prescription medical treatments, today announced $30 million in debt financing from K2 HealthVentures (K2HV), a healthcare-focused specialty finance company, to accelerate commercialization of its leading smoking cessation solution, Clickotine™, and to advance its pipeline of clinically-validated digital therapeutics [Read more…] about Click Therapeutics raises $30 million in debt to advance commercialization of smoking cessation app Clickotine
Brain-computer interface (BCI) technologies are no longer hypothetical, yet there are fundamental aspects of the technology that remain unaddressed by both ethicists and policy-makers. Two new papers address these issues by outlining the outstanding ethical issues, offering guidance for addressing those issues, and offering particular insight into the field of BCI tech for cognitive enhancement. [Read more…] about Studies identify key ethical concerns raised by invasive and non-invasive neurotechnologies
When: Tuesday, April 28th, 9am — 6pm US Pacific Time (San Francisco time zone)
What: Find Wellbeing During Covid19 — Discover 200+ Free and Discounted Tools to help you find some relief and emerge even stronger
How: Learn More and Register HERE
Confirmed Speakers include:
Decades from now when our augmented brains have enhanced our cognitive function and transformed nearly every aspect of our lives, many of us will look back and wonder why we didn’t do more to prepare for these inevitable changes. Government leaders may grapple with the runaway effects of AI and brain enhancement on geopolitics. Companies that fail to incorporate neurotechnologies and BCI into their operational flow could lose significant market share and be forced to scramble in an attempt to regain a foothold in an industry they once dominated.
Workers who don’t heed the warnings to re-skill or upskill may find themselves out of a job as entire industries disappear. Graduating college students may discover their field of study is no longer relevant in the business world, leaving them unprepared for the changing job market. Tech innovators could be caught up in fierce competition to snap up employees from a very limited talent pool, driving up the cost of innovation and hampering its development. And everyday citizens may be wrestling with the unexpected consequences of unintentionally giving away the rights to their neural data.
Rest assured, it doesn’t have to be this way. [Read more…] about Fast Forward to 2040: How to prepare for the new era in brain enhancement that will change the way we think, work, and heal
“Digital therapeutic company Akili Interactive has announced the first results of an open-label, multisite pediatric ADHD trial providing some patients with the company’s video game-like treatment alongside a stimulant medication.
According to the company, both those who received the AKL-T01 therapy with (n = 130) or without (n = 76) accompanying stimulant medication saw significant improvements one month after [Read more…] about Will digital therapeutics complement or replace stimulant medications to address inattention and “silent” cognitive issues?
“The futuristic promise of tech devices that use brain waves to improve sleep, anxiety and concentration — and even control prosthetic hands — may finally be coming to fruition, with a slew of new products on display at CES 2020 in Las Vegas. Brain tech holds great potential for helping us understand and control our minds from the comfort of our homes, but science still has a long way to go.
Here are some of the coolest brain tech products we saw at CES 2020. Some of these products are already on the market, while some are only prototypes.” Continue reading over at CNET